An interview with Masaki Sudo, President & CEO of RaQualia Pharma Inc., has been published by The Worldfolio , a global news media agency specializing in industrial and business coverage.
The article highlights the core strengths of Japan’s pharmaceutical industry, including its adaptation to emerging therapeutic modalities. It also presents RaQualia’s focused therapeutic areas and upcoming key milestones, as well as future business development plans for tegoprazan.
The Worldfolio: How RaQualia Turns Molecules into Meaning
https://www.theworldfolio.com/interviews/how-raqualia-turns-molecules-into-meaning/6983/